Genomic Valley (539206)

STALWART

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹52
Market Cap₹15.99 Cr
P/E Ratio0
ROCE11.84%
ROE-1.15%
Dividend Yield0%
Profit Growth-93.75%
Debt/Equity—
Sales Growth-77.27%
52-Week Range₹20.1 — ₹54.27
SectorPharmaceuticals & Biotechnology
Book Value₹12.28

Genomic Valley trades with ROCE of 11.84%, ROE of -1.15%, profit growth of -93.75%.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer